logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates17.144.864.662.650.857.345.724.12711194
Cocaine2.13.65.29.29.95.37.41.726661
Stimulants20.224.515.410.811.16.97.41.7107953
Hypnotics and sedatives2.52.32.94.514.716.823.555.2282141
Hallucinogens0.10.10.20.00.00.00.00.064
Volatile substances8.73.20.60.40.00.00.00.91629
Cannabis 48.620.610.411.011.111.58.63.41167129
Other substances 0.71.00.81.62.42.37.412.979126
Total84224591315556252131811165752717

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010